Recall: D-0425-2026
Class II - Potentially Harmful
Class IIClassification
2026-03-11Initiated
OngoingStatus
Fresenius Kabi USA, LLCFirm
Product
0.9% Sodium Chloride Injection, USP 0.9% (450 mg per 50 mL) (9 mg per mL) 50 mL, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-466-05, Unit of Sale NDC Number: 65219-466-60.
Reason
Lack of Assurance of Sterility
Distribution
US Nationwide , Alaska, and Puerto Rico.
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.